Société Fujian Cosunter Pharmaceutical Co., Ltd.
Actions
300436
CNE100001YZ0
Produits pharmaceutiques
Cours en clôture
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
16 CNY | -7,08% | -0,25% | -37,57% |
Métier
Ventes par activité
CNY en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Liver-protecting Drugs
48,0
%
| 178 | 46,1 % | 203 | 48,0 % | +13,94% |
Anti-hepatitis B Virus Drugs
28,8
%
| 155 | 40,2 % | 122 | 28,8 % | -21,54% |
Cardiovascular Drugs
8,4
%
| 22 | 5,8 % | 36 | 8,4 % | +58,14% |
Anti-coronavirus Drugs
5,0
%
| - | - | 21 | 5,0 % | - |
Digestive System Drugs
4,5
%
| 18 | 4,8 % | 19 | 4,5 % | +2,25% |
Men's Health Products
2,5
%
| 3 | 0,7 % | 10 | 2,5 % | +314,68% |
Other
2,2
%
| 6 | 1,6 % | 9 | 2,2 % | +56,44% |
Respiratory Drugs
0,7
%
| 3 | 0,9 % | 3 | 0,7 % | -6,31% |
Ventes par région
CNY en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
China
100,0
%
| 386 | 100,0 % | 423 | 100,0 % | +9,58% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Guo Ping Li
CEO | Chief Executive Officer | 56 | 28/06/01 |
Jian Hui Guan
DFI | Director of Finance/CFO | 48 | 25/07/17 |
Yuan Li Li
CHM | Chairman | 66 | 01/01/11 |
Hong Ming Li
COO | Chief Operating Officer | 55 | 06/01/21 |
Fu hu Huang
BRD | Director/Board Member | 48 | 20/09/16 |
Guo Dong Li
BRD | Director/Board Member | 53 | 01/01/02 |
Yang Ding
IRC | Investor Relations Contact | 42 | - |
Qing He Zhang
PRN | Corporate Officer/Principal | - | 04/05/23 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Guo Ping Li
CEO | Chief Executive Officer | 56 | 28/06/01 |
Li Qing Ye
BRD | Director/Board Member | 54 | 20/09/11 |
Guo Dong Li
BRD | Director/Board Member | 53 | 01/01/02 |
Yuan Li Li
CHM | Chairman | 66 | 01/01/11 |
Hong Ren
BRD | Director/Board Member | 64 | 06/01/21 |
Fu hu Huang
BRD | Director/Board Member | 48 | 20/09/16 |
Xiao Yang Guo
BRD | Director/Board Member | 56 | 23/08/21 |
Ming Yu Chen
BRD | Director/Board Member | 61 | 20/12/17 |
Xin Rong Qiang
BRD | Director/Board Member | 52 | 20/12/17 |
Hong Ming Li
COO | Chief Operating Officer | 55 | 06/01/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 159 267 000 | 80 116 648 ( 50,30 %) | 0 | 50,30 % |
Coordonnées société
Fujian Cosunter Pharmaceutical Co., Ltd.
Bldg16, Phase II, Innovation Park No. 7 Wulongjiang Middle Avenue
350108, Fuzhou
+
http://www.cosunter.comSecteur
Ventes par activité
Bénéfices annuels - Taux de surprise
Varia. 1 janv. | Capi. | |
---|---|---|
-37,57% | 351 M | |
+55,19% | 801 Md | |
+47,26% | 631 Md | |
-6,09% | 359 Md | |
+21,92% | 337 Md | |
+18,40% | 245 Md | |
+3,64% | 231 Md | |
+12,98% | 219 Md | |
+10,86% | 171 Md | |
-2,78% | 161 Md |
- Bourse
- Actions
- Action 300436
- Société Fujian Cosunter Pharmaceutical Co., Ltd.